Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study.

Literature DB >> 25887499

Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: a multicenter retrospective cohort study.

Nicoletta Riva¹, Matteo N D Di Minno², Nicola Mumoli³, Fulvio Pomero⁴, Massimo Franchini⁵, Marta Bellesini⁶, Roberta Lupoli⁷, Silvia Sabatini³, Valentina Borretta⁴, Carlo Bonfanti⁵, Walter Ageno⁶, Francesco Dentali⁶.

Abstract

Entities: Chemical Disease

Keywords: bleeding; cohort study; statins; venous thromboembolism; vitamin K antagonist

Mesh：

Substances：

Year: 2015 PMID： 25887499 PMCID： PMC5004428 DOI： 10.3324/haematol.2015.127183

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

14 in total

Review 1. Statins for acute ischemic stroke.

Authors: Alessandro Squizzato; Erica Romualdi; Francesco Dentali; Walter Ageno
Journal: Cochrane Database Syst Rev Date: 2011-08-10

2. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal: Ann Intern Med Date: 2007-10-16 Impact factor: 25.391

3. High-dose atorvastatin after stroke or transient ischemic attack.

Authors: Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal: N Engl J Med Date: 2006-08-10 Impact factor: 91.245

Review 4. Anticoagulant effects of statins and their clinical implications.

Authors: A Undas; K E Brummel-Ziedins; K G Mann
Journal: Thromb Haemost Date: 2013-11-28 Impact factor: 5.249

5. Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case-control study.

Authors: M Schmidt; S C Cannegieter; S A Johannesdottir; O M Dekkers; E Horváth-Puhó; H T Sørensen
Journal: J Thromb Haemost Date: 2014-06-19 Impact factor: 5.824

6. Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?

Authors: James D Douketis; Magda Melo; Chaim M Bell; Muhammad M Mamdani
Journal: Am J Med Date: 2007-04 Impact factor: 4.965

7. Statin treatment and the risk of recurrent pulmonary embolism.

Authors: Sara Biere-Rafi; Barbara A Hutten; Alessandro Squizzato; Walter Ageno; Patrick C Souverein; Anton de Boer; Victor E A Gerdes; Harry R Büller; Pieter W Kamphuisen
Journal: Eur Heart J Date: 2013-02-08 Impact factor: 29.983

8. Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism. A multicentre retrospective cohort study.

Authors: N Riva; M Bellesini; M N D Di Minno; N Mumoli; F Pomero; M Franchini; C Fantoni; R Lupoli; B Brondi; V Borretta; C Bonfanti; W Ageno; F Dentali
Journal: Thromb Haemost Date: 2014-06-05 Impact factor: 5.249

2. Shrinking Weibel-Palade bodies prevents high platelet recruitment in assays using thrombotic thrombocytopenic purpura plasma.

Authors: Francesca Patella; Chiara Vendramin; Oscar Charles; Marie A Scully; Daniel F Cutler
Journal: Res Pract Thromb Haemost Date: 2021-12-07

2 in total